Table 3 Survey response to clinical scenario of SEP management
From: Management of status epilepticus in pregnancy: a clinician survey
Which second line anti-seizure medication would you choose? (n = 97) | |
Levetiracetam | 87 |
Fos-phenytoin/phenytoin | 4 |
Valproate | 0 |
Lacosamide | 0 |
Phenobarbital | 0 |
Magnesium | 6 |
Other | 0 |
Is this choice different from your typical choice? | |
Yes | 27 |
No | 70 |
If a second, second line anti-seizure medication is needed what would you choose? (n = 98) | |
Levetiracetam | 8 |
Fos-phenytoin/phenytoin | 20 |
Valproate | 3 |
Lacosamide | 60 |
Phenobarbital | 3 |
Magnesium | 3 |
Other | 1 |
Is this choice different from your typical choice? | |
Yes | 48 |
No | 50 |
What anesthetic drip do you choose to treat refractory SE in pregnancy? (n = 100) | |
Propofol | 36 |
Midazolam | 60 |
Ketamine | 2 |
Pentobarbital | 1 |
Sevoflurane | 0 |
Other | 1 |
Is this choice different from your typical choice? | |
Yes | 18 |
No | 82 |
What alternative treatments for super refractory SE have you used in pregnant patients?* | |
Therapeutic hypothermia | 8 |
Ketogenic diet | 7 |
High dose steroids | 18 |
Plasma exchange | 7 |
Trans-magnetic stimulation | 2 |
Neurosurgical intervention | 7 |
Other | 10 |
None | 63 |